NASDAQ: LNSR - LENSAR, Inc.

Yield per half year: +94.43%
Dividend yield: 0.00%
Sector: Healthcare

Share chart LENSAR, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

more details
The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-10-02
ISIN US52634L1089
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.lensar.com
Цена ао 3.54
Change price per day: +0.1195% (8.37)
Change price per week: +8.83% (7.7)
Change price per month: +8.97% (7.69)
Change price per 3 month: +88.74% (4.44)
Change price per half year: +94.43% (4.31)
Change price per year: +138.75% (3.51)
Change price per 3 year: +39.2% (6.02)
Change price per 5 year: 0% (8.38)
Change price per 10 year: 0% (8.38)
Change price per year to date: +13.55% (7.38)
All parameters

Underestimation

Title Value Grade
P/S 0.8613 9
P/BV 0.7698 9
P/E 0 0
EV/EBITDA -2.07 0
Total: 6

Efficiency

Title Value Grade
ROA, % -20.67 0
ROE, % -30.49 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.265 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 38.24 5
Yield Ebitda, % -0.9773 0
Yield EPS, % -16.5 0
Total: 1
More

Institutions Volume Share, %
Park West Asset Management LLC 1115686 9.79
Dimensional Fund Advisors LP 660682 5.8
Vanguard Group Inc 433474 3.8
Renaissance Technologies, LLC 314438 2.76
DCF Advisers, LLC 240534 2.11
Brandes Investment Partners L.P. 226676 1.99
Clearline Capital, LP 173004 1.52
Blackrock Inc. 156951 1.38
Geode Capital Management, LLC 89183 0.78
RBF Capital, LLC 50074 0.44

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00935 17.09 1.54048
Dimensional U.S. Targeted Value ETF 0.00231 26.01 1.93487
Dimensional U.S. Core Equity 2 ETF 0.00016 30.76 1.47098
Dimensional U.S. Equity ETF 0.00004 31.53 1.3557



Head Job title Payment Year of birth
Mr. Nicholas T. Curtis President, CEO & Director 974.29k 1956 (69 years)
Mr. Thomas R. Staab II, CPA CFO & Secretary 612.55k 1968 (57 years)
Mr. Alan B. Connaughton Chief Operating Officer 650.62k 1972 (53 years)
Ms. Kendra W. Wong Principal Accounting Officer N/A 1980 (45 years)

Address: United States, Orlando. FL, 2800 Discovery Drive - open in Google maps, open in Yandex maps
Website: https://www.lensar.com